Press Release Nov 03 2022
Filed with NSE · · 3 pages · English
Summary by 6ix AI
Zydus Lifesciences Limited has issued a press release regarding new data presentations at The Liver Meeting in Washington, DC. The company will present four abstracts on Saroglitazar Mg, with two awarded the AASLD Presidential Poster Of Distinction. The USFDA and EMA have granted special designations for Saroglitazar Mg related to Primary Biliary Cholangitis.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Zydus Lifesciences Limited on 6ix
Earlier from Zydus Lifesciences
- Press Release Oct 29 2022
- Press Release Oct 26 2022
- Press Release Oct 22 2022
- Press Release Oct 17 2022
- Zydus Lifesciences: General updates
Later from Zydus Lifesciences
- Press Release Nov 07 2022
- Press Release Nov 08 2022
- Press Release Nov 16 2022
- Press Release Nov 23 2022
- Press Release Nov 28 2022
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences